American Oriental Bioengineering Proposes Offering of $85 Million of Convertible Notes (PR Newswire)
American Oriental Bioengineering, Inc. today announced its intention to offer, subject to market conditions and other factors, $85 million aggregate principal amount of Convertible Senior Notes due 2015 to qualified institutional buyers in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended .
 

More

  • CHOCOLATE CANDY CREATIONS, INC. (form S-1)

    CHOCOLATE CANDY CREATIONS, INC. Files SEC form S-1, Securities Registration Statement

  • Rexahn Pharmaceuticals Receives AMEX Listing Approval (Business Wire)

    ROCKVILLE, Md.----Rexahn Pharmaceuticals, Inc. , a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs, announced today that its common shares have been approved for listing on the American Stock Exchange and are expected to commence trading at the opening of the market on Tuesday, May 27, 2008.